EX-15.1 3 exhibit151-2018q1.htm EXHIBIT 15.1 Exhibit


Exhibit 15.1


February 7, 2018


Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549


Commissioners:

We are aware that our report dated February 7, 2018 on our review of interim financial information of Varian Medical Systems, Inc. for the three month periods ended December 29, 2017 and December 30, 2016 and included in the Company's quarterly report on Form 10-Q for the quarter ended December 29, 2017 is incorporated by reference in its Registration Statements on Form S-3 (No. 333-221763) and Form S‑8 (No. 333-220078, No.333-188693, No.333-168444, No. 333-168443, No. 333-146176, No. 333-130001, No. 333-152903, No. 333-123778, No. 333-75531, No. 333-57006, No. 333-57008, No. 333-57010, and No. 333-161307).

Very truly yours,


/S/ PRICEWATERHOUSECOOPERS LLP
PricewaterhouseCoopers LLP


PricewaterhouseCoopers LLP, 488 Almaden Boulevard, Suite 1800, San Jose, CA 95110
T: (408) 817 3700, F: (408) 817 5050, www.pwc.com/us